MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 194 filers reported holding MEDICINES CO in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,825,000 | +79.9% | 186,317 | +5.9% | 0.02% | +46.7% |
| Q3 2019 | $8,795,000 | +1979.2% | 175,918 | +1417.3% | 0.02% | +1400.0% |
| Q2 2019 | $423,000 | -40.8% | 11,594 | -54.7% | 0.00% | 0.0% |
| Q1 2019 | $715,000 | -61.6% | 25,572 | -73.7% | 0.00% | -75.0% |
| Q4 2018 | $1,864,000 | +403.8% | 97,368 | +766.5% | 0.00% | +300.0% |
| Q1 2018 | $370,000 | +83.2% | 11,237 | +52.3% | 0.00% | 0.0% |
| Q4 2017 | $202,000 | -83.3% | 7,380 | -76.8% | 0.00% | -80.0% |
| Q2 2017 | $1,210,000 | -72.8% | 31,855 | -64.9% | 0.01% | -75.0% |
| Q1 2017 | $4,444,000 | +504.6% | 90,880 | +319.3% | 0.02% | +566.7% |
| Q4 2016 | $735,000 | +214.1% | 21,672 | +249.9% | 0.00% | +200.0% |
| Q3 2016 | $234,000 | -87.3% | 6,193 | -88.7% | 0.00% | -88.9% |
| Q2 2016 | $1,846,000 | +104.7% | 54,906 | +127.3% | 0.01% | +80.0% |
| Q4 2015 | $902,000 | -12.7% | 24,154 | -11.2% | 0.01% | -16.7% |
| Q3 2015 | $1,033,000 | +236.5% | 27,203 | +148.5% | 0.01% | +200.0% |
| Q1 2015 | $307,000 | – | 10,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
| Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
| BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
| HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
| Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
| Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
| Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
| Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
| DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
| Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |